Skip to main content
Erschienen in: Supportive Care in Cancer 2/2021

28.05.2020 | Original Article

Patient acceptance of prehabilitation for major surgery: an exploratory survey

verfasst von: Jamie L. Waterland, Hilmy Ismail, Babak Amin, Catherine L. Granger, Linda Denehy, Bernhard Riedel

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Prehabilitation programs are effective in optimising patient’s functional reserve prior to surgery and increasingly associated with reduced postoperative complications. However, acceptability of programs among patients is largely unknown. This study set out to explore the acceptability of prehabilitation from the perspective of patients awaiting major cancer surgery.

Methods

Adult patients awaiting major gastrointestinal and urological cancer surgeries were surveyed. Patients were excluded if they were unable to complete the survey due to language, intellectual impairment and/or visual/hearing deficit. The survey was designed to explore categories related to patient demographics, level of physical activity and perceived enablers and barriers to prehabilitation.

Results

One hundred and three participants presenting to a pre-anaesthesia clinic completed the survey over a 5-month period, with 83% response rate. Approximately, half of the respondents were female (55%) and were currently physically active (53%). Fewer than one third (30%) felt they completed ‘enough exercise’. The majority of participants (83%) were unfamiliar with the concept of prehabilitation but two thirds (68%) were interested in such a program after explanation. The majority of participants (72%) indicated a strong preference to exercise in a home-based environment. Medical recommendation increased willingness to participate (p < 0.001), while program costs (p = 0.01) were potential barriers to participation.

Conclusion

Patients are willing to participate in prehabilitation prior to major cancer surgery but practical barriers and facilitators should be considered when designing prehabilitation programs to maximise patient commitment to facilitate improved postoperative outcomes.
Literatur
1.
Zurück zum Zitat Carli F, Silver JK, Feldman LS, McKee A, Gilman S, Gillis C, Scheede-Bergdahl C, Gamsa A, Stout N, Hirsch B (2017) Surgical prehabilitation in patients with cancer: state-of-the-science and recommendations for future research from a panel of subject matter experts. Phys Med Rehabil Clin N Am 28(1):49–64CrossRef Carli F, Silver JK, Feldman LS, McKee A, Gilman S, Gillis C, Scheede-Bergdahl C, Gamsa A, Stout N, Hirsch B (2017) Surgical prehabilitation in patients with cancer: state-of-the-science and recommendations for future research from a panel of subject matter experts. Phys Med Rehabil Clin N Am 28(1):49–64CrossRef
2.
Zurück zum Zitat Barberan-Garcia A, Ubre M, Roca J, Lacy AM, Burgos F, Risco R, Momblan D, Balust J, Blanco I, Martinez-Palli G (2018) Personalised prehabilitation in high-risk patients undergoing major abdominal surgery: a randomized blinded controlled trial. Ann Surg 267(1):50–56CrossRef Barberan-Garcia A, Ubre M, Roca J, Lacy AM, Burgos F, Risco R, Momblan D, Balust J, Blanco I, Martinez-Palli G (2018) Personalised prehabilitation in high-risk patients undergoing major abdominal surgery: a randomized blinded controlled trial. Ann Surg 267(1):50–56CrossRef
3.
Zurück zum Zitat Boden I, Skinner EH, Browning L, Reeve J, Anderson L, Hill S, Robertson IK, Story D, Denehy L (2018) Preoperative physiotherapy for the prevention of respiratory complications after upper abdominal surgery: pragmatic, double blinded, multicentre randomised controlled trial. BMJ 360 (j5916) Boden I, Skinner EH, Browning L, Reeve J, Anderson L, Hill S, Robertson IK, Story D, Denehy L (2018) Preoperative physiotherapy for the prevention of respiratory complications after upper abdominal surgery: pragmatic, double blinded, multicentre randomised controlled trial. BMJ 360 (j5916)
4.
Zurück zum Zitat Sebio Garcia R, Yanez Brage MI, Gimenez Moolhuyzen E, Granger CL, Denehy L (2016) Functional and postoperative outcomes after preoperative exercise training in patients with lung cancer: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 23(3):486–497CrossRef Sebio Garcia R, Yanez Brage MI, Gimenez Moolhuyzen E, Granger CL, Denehy L (2016) Functional and postoperative outcomes after preoperative exercise training in patients with lung cancer: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg 23(3):486–497CrossRef
6.
Zurück zum Zitat Minnella EM, Liberman AS, Charlebois P, Stein B, Scheede-Bergdahl C, Awasthi R, Gillis C, Bousquet-Dion G, Ramanakuma AV, Pecorelli N, Feldman LS, Carli F (2019) The impact of improved functional capacity before surgery on postoperative complications: a study in colorectal cancer. Acta Oncol 58(5):573–578CrossRef Minnella EM, Liberman AS, Charlebois P, Stein B, Scheede-Bergdahl C, Awasthi R, Gillis C, Bousquet-Dion G, Ramanakuma AV, Pecorelli N, Feldman LS, Carli F (2019) The impact of improved functional capacity before surgery on postoperative complications: a study in colorectal cancer. Acta Oncol 58(5):573–578CrossRef
8.
Zurück zum Zitat Cho OH (2004) Effects of a comprehensive rehabilitation program for mastectomy patients. Taehan Kanho Hakhoe Chi 34(5):809–819PubMed Cho OH (2004) Effects of a comprehensive rehabilitation program for mastectomy patients. Taehan Kanho Hakhoe Chi 34(5):809–819PubMed
9.
Zurück zum Zitat Ferriera V, Agnihotram RV, Bergdahl A, van Rooijen SJ, Awasthi R, Carli F, Scheede-Bergdahl C (2018) Maximizing patient adherence to prehabilitation: what do the patients say? Support Care Cancer 26:2717–2723CrossRef Ferriera V, Agnihotram RV, Bergdahl A, van Rooijen SJ, Awasthi R, Carli F, Scheede-Bergdahl C (2018) Maximizing patient adherence to prehabilitation: what do the patients say? Support Care Cancer 26:2717–2723CrossRef
10.
Zurück zum Zitat University of Southampton and Wessex Voices (2017) Patients’ experience of exercise and cancer. Informing ‘WESFIT’ Pilot Patient Involvement Report Feedback to participants University of Southampton and Wessex Voices (2017) Patients’ experience of exercise and cancer. Informing ‘WESFIT’ Pilot Patient Involvement Report Feedback to participants
11.
Zurück zum Zitat Saegrov S, Halding A-G (2004) What is it like living with the diagnosis of cancer? European Journal of Cancer Care 13:145–153CrossRef Saegrov S, Halding A-G (2004) What is it like living with the diagnosis of cancer? European Journal of Cancer Care 13:145–153CrossRef
12.
Zurück zum Zitat Booth ML (2000) Assessment of physical activity: an international perspective. Res Q Exerc Sport 71(2):s114–s120CrossRef Booth ML (2000) Assessment of physical activity: an international perspective. Res Q Exerc Sport 71(2):s114–s120CrossRef
14.
Zurück zum Zitat Cancer Research UK (2008) Perceptions of risk survey 2008: key findings Cancer Research UK (2008) Perceptions of risk survey 2008: key findings
16.
Zurück zum Zitat Santa Mina D, Petrella A, Matthew AG (2015) Enablers and barriers in delivery of a cancer exercise program: the Canadian experience. Curr Oncol 22(6):372–384CrossRef Santa Mina D, Petrella A, Matthew AG (2015) Enablers and barriers in delivery of a cancer exercise program: the Canadian experience. Curr Oncol 22(6):372–384CrossRef
Metadaten
Titel
Patient acceptance of prehabilitation for major surgery: an exploratory survey
verfasst von
Jamie L. Waterland
Hilmy Ismail
Babak Amin
Catherine L. Granger
Linda Denehy
Bernhard Riedel
Publikationsdatum
28.05.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 2/2021
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05547-1

Weitere Artikel der Ausgabe 2/2021

Supportive Care in Cancer 2/2021 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.